Trial Profile
A Randomized, Double-Blind, Double-Dummy, Placebo And Active Controlled Two Period Four Treatment Cross-Over Clinical Trial To Examine The Pain Relief Of PH-797804 Alone Or With Naproxen In Subjects With Flare-Enriched Osteoarthritis Of The Knee.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Oct 2014
Price :
$35
*
At a glance
- Drugs PH 797804 (Primary) ; Naproxen
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Pfizer
- 18 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Nov 2010 Planned end date changed from 1 Feb 2011 to 1 Mar 2011 as reported by ClinicalTrials.gov.
- 07 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.